Cite
HARVARD Citation
Yamazaki, K. et al. (n.d.). 74TiPPhase I study of BI 836880, a VEGF/Ang2-blocking nanobody®, as monotherapy and in combination with BI 754091, an anti-PD-1 antibody, in Japanese patients (pts) with advanced solid tumours. Annals of oncology. p. . [Online].